Catalyst Pharmaceuticals position history
The shares of Catalyst Pharmaceuticals that THIRD AVENUE MANAGEMENT LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2026 Q1: 210,161 shares, $5.2M, 0.84% of portfolio, New
- 2026 Q2: 210,161 shares, $6.6M, 1.1% of portfolio
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|